Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer

BACKGROUND: The clinical significance of progesterone receptor (PgR) expression in estrogen receptor-negative (ER–) breast cancer is controversial. Herein, we systemically investigate the clinicopathologic features, molecular essence, and endocrine responsiveness of ER−/PgR+/HER2− phenotype. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ke-Da, Jiang, Yi-Zhou, Hao, Shuang, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595063/
https://www.ncbi.nlm.nih.gov/pubmed/26437901
http://dx.doi.org/10.1186/s12916-015-0496-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595063/
https://www.ncbi.nlm.nih.gov/pubmed/26437901
http://dx.doi.org/10.1186/s12916-015-0496-z

Ejemplares similares